Medicinal Plant and Traditional Knowledge-guided Strategies to Combat HIV Persistence
- 29 November 2024
- journal article
- review article
- Published by Springer Nature in Current HIV/AIDS Reports
- Vol. 22 (1) , 1-12
Abstract
Purpose of Review Combination antiretroviral therapy (cART) does not act on latent HIV reservoirs, and no latency-reversing agent (LRA) to date consistently reduces viral reservoirs in humans. In Sub-Saharan Africa and elsewhere, complementary and alternative medicines (CAM) are traditionally used to manage HIV/AIDS, including a subset with LRA properties. Recent Findings Several plants from the Euphorbiaceae and Thymelaeaceae families have been recently documented for traditional HIV/AIDS management and contain LRAs that function through protein kinase C activation. These CAM are increasingly validated in HIV-infected primary cells and humanized mice. Engagement with traditional health practitioners (THPs) which prioritizes data and benefits sharing can improve trust relations, build long-term collaborations, and advance mutual knowledge on these unique CAM. Summary CAM used traditionally for HIV/AIDS management include LRAs already used by humans, but more study and collaboration with THPs are needed to understand their potential to support global cART-free HIV remission and cure efforts.Keywords
Funding Information
- Sub-Saharan African Network for TB/HIV Research Excellence (DEL-15-006)
- Sub-Saharan African Network for TB/HIV Research Excellence (DEL-15-006)
- Sub-Saharan African Network for TB/HIV Research Excellence (DEL-15-006)
- Canadian Institutes of Health Research (PJT-153057)
- Canadian Institutes of Health Research (PJT-153057)
- W. W. Smith Charitable Trust (A2301)
- Penn Center for AIDS Research (P30 AI 045008)
This publication has 65 references indexed in Scilit:
- Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDSEuropean Journal of Pharmaceutics and Biopharmaceutics, 2024
- Medicinal plants used by traditional medicine practitioners to boost the immune system in people living with HIV/AIDS in UgandaEuropean Journal of Integrative Medicine, 2020
- Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infectionsAntiviral Research, 2019
- HIV “shock and kill” therapy: In need of revisionAntiviral Research, 2019
- Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirsCellular and Molecular Life Sciences, 2019
- Natural product-derived compounds in HIV suppression, remission, and eradication strategiesAntiviral Research, 2018
- Identification, structural modification, and dichotomous effects on human immunodeficiency virus type 1 (HIV-1) replication of ingenane esters from Euphorbia kansuiEuropean Journal of Medicinal Chemistry, 2018
- “Now I Heal with Pride”—The Application of Screens-to-Nature Technology to Indigenous Knowledge Systems Research in Botswana: Implications for Drug Discovery2012
- The protein kinase C activators, phorbol 12-myristate,13-acetate and phorbol 12,13-dibutyrate, are convulsant in the pico-nanomolar range in miceEuropean Journal of Pharmacology, 1992
- New tigliane and daphnane derivatives fromPimelea prostrata andPimelea simplexCellular and Molecular Life Sciences, 1977